Review: Evolution of evidence on PFOA and health following the assessments of the C8 Science Panel.

Kyle Steenland, Tony Fletcher, Cheryl R Stein, Scott M Bartell, Lyndsey Darrow, Maria-Jose Lopez-Espinosa, P Barry Ryan, David A Savitz

Journal: Environment international 2021;145():106125

PMID: 32950793

Abstract

BACKGROUND

The C8 Science Panel was composed of three epidemiologists charged with studying the possible health effects of PFOA in a highly exposed population in the mid-Ohio Valley. The Panel determined in 2012 there was a 'probable link' (i.e., more probable than not based on the weight of the available scientific evidence) between PFOA and high cholesterol, thyroid disease, kidney and testicular cancer, pregnancy-induced hypertension, and ulcerative colitis.

OBJECTIVE

Here, former C8 Science Panel members and collaborators comment on the PFOA literature regarding thyroid disorders, cancer, immune and auto-immune disorders, liver disease, hypercholesterolemia, reproductive outcomes, neurotoxicity, and kidney disease. We also discuss developments regarding fate and transport, and pharmacokinetic models, and discuss causality assessment in cross-sectional associations among low-exposed populations.

DISCUSSION

For cancer, the epidemiologic evidence remains supportive but not definitive for kidney and testicular cancers. There is consistent evidence of a positive association between PFOA and cholesterol, but no evidence of an association with heart disease. There is evidence for an association with ulcerative colitis, but not for other auto-immune diseases. There is good evidence that PFOA is associated with immune response, but uneven evidence for an association with infectious disease. The evidence for an association between PFOA and thyroid and kidney disease is suggestive but uneven. There is evidence of an association with liver enzymes, but not with liver disease. There is little evidence of an association with neurotoxicity. Suggested reductions in birthweight may be due to reverse causality and/or confounding. Fate and transport models and pharmacokinetic models remain central to estimating past exposure for new cohorts, but are difficult to develop without good historical data on emissions of PFOA into the environment.

CONCLUSION

Overall, the epidemiologic evidence remains limited. For a few outcomes there has been some replication of our earlier findings. More longitudinal research is needed in large populations with large exposure contrasts. Additional cross-sectional studies of low exposed populations may be less informative.

Copyright © 2020. Published by Elsevier Ltd.

Address: 1518 Clifton Rd, Rollins School of Public Health, Emory U., Atlanta, GA 30324, United States. Electronic address: [email protected].; London School of Hygiene and Tropical Medicine, London, United Kingdom.; Hassenfeld Children's Hospital at NYU Langone, NY, NY, United States.; Program in Public Health, University of California Irvine, Irvine, Cal, United States.; University of Nevada, Reno, Nev, United States.; Epidemiology and Environmental Health Joint Research Unit, FISABIO, Universitat Jaume I-Universitat de València, Valencia, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.; 1518 Clifton Rd, Rollins School of Public Health, Emory U., Atlanta, GA 30324, United States.; Brown University School of Public Health, Providence, Rhode Island, United States.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.